Digital Health Platforms Buy and Build
The concept of connected care has created integrated platforms that house software-based products, offerings and services related to healthcare. The aim is to keep people healthy through predictive diagnoses, to optimise the delivery of patient care through offerings that show a clear benefit, and to respond to growing demands for cost saving solutions. So what […]
The State of Pharma Contract Development and Manufacturing Organizations
When we talk about contract drug and manufacturing organizations (CDMOs), we are really talking about a diverse group of companies that serve pharma/biotech/academia in a variety of ways, from discovery through to commercialization opportunities. These companies constitute a very broad and quite fragmented ecosystem, which continues to grow because (ultimately) Big Pharma intends to continue […]
What We Can Do about Wasted Pharmaceuticals
The medicine is still perfectly good. Millions of uninsured or underinsured people need the drugs. Yet the pharmaceutical industry incinerates billions of dollars’ worth of unopened, unused, and unexpired drugs each year in America. This waste leads to both economic and environmental challenges. The good news is the problems companies create when they destroy unused […]
Challenges and Opportunities in Australia’s Radiology Industry
Australia’s aging population creates a changing environment for health service businesses in the nation and, in particular, radiology service providers. Specifically, radiology is the diagnostic approach to detect illnesses using radiation. Ultrasound, X-rays, MRIs, PET/CT (positron emission tomography and computer-aided tomography) scans, and nuclear medicine. For an informed view of what likely lies ahead, GLG’s […]
The Inflation Reduction Act: What Drugmakers Should Know
The Inflation Reduction Act is one of the Biden administration’s signature pieces of legislation, and its drug pricing provisions should bring major changes to America’s pharmaceutical industry. New rules will likely affect the bottom lines of drugmakers, trim margins for pharmacy benefit managers, and lower out-of-pocket costs for Medicare beneficiaries. But changing the intricacies of […]
Looking at the Australian National Disability Insurance Scheme (NDIS)
According to a report by the Australian Associated Press, there is bipartisan support for the National Disability Insurance Scheme (NDIS) despite ongoing criticism over rising costs. The cost of NDIS is anticipated to climb $8.8 billion over the next four years and approach $50 billion annually by 2025-26. Nevertheless, Australia’s prime minister says that the […]
At-Home Healthcare After COVID-19
With the rapid spread of COVID-19, at-home healthcare became more important than ever. But how were healthcare providers able to pivot to provide adequate care to patients who were already struggling to manage their chronic health conditions? GLG’s Frank Fox spoke with former GLG Social Impact Fellow and CHW Cares Founder Manmeet Kaur to learn […]
TPP Testing in Pharma: Best Practices
Companies regularly test new concepts to stimulate innovation and minimize commercial and financial risk ahead of major business decisions, such as product acquisition, development, and launch. A framed and systematic research methodology showcases concepts with different features and benefits to potential or existing customers. This helps validate a value proposition and estimate its market potential. […]
Drilling into Dental Industry Trends
Over the past few years, the dental industry, like many other industries, has experienced changes that have occurred at an accelerated rate. COVID-19 and its related shutdowns and restrictions had a significant impact on dental practices, but patients are back, and the dentistry industry seems to be exceeding pre-pandemic levels. To discuss this and other […]
Radiation Oncology Market: The Battle for Doctors
To thrive in the competitive radiation oncology marketplace, companies must have referring doctors on their side. It’s the most important element. Even massive, international companies like GenesisCare and Icon rely on individual patients to fuel their revenue streams. Different regions of the world have different characteristics for patient referrals. In a recent teleconference, GLG’s Xavier […]
GLG Institute’s “Effective Leadership Development in a Post-COVID World” roundtable highlights
There are significant disruptions in the world of work. The events and crises during 2020-21 (health, economic, environmental, political, employment, social and racial justice, etc.) magnified previously existing inequities and forced organizations to adapt, transform and reinvent. On November 3, GLG Institute organized a 90-minute roundtable attended by senior HR and business leaders in the […]
Analyzing Australia’s Response to COVID-19
How has Australia responded to the COVID-19 pandemic and the delta variant, and how is it positioned to deal with the pandemic’s evolving challenges? To find out, GLG recently held a remote roundtable with two public health experts: Dr. Stephen Ostroff, a longtime senior official at the U.S. Centers for Disease Control and Prevention and […]